Biotech

All Articles

ArsenalBio elevates $325M, rotates out of former lead property

.Collection Biosciences is actually carrying on up. The cell treatment company has actually added on...

Lilly- supported weight reduction biotech documents IPO

.After raising $170 million back in February, metabolic disease-focused BioAge Labs has actually sub...

Aelis' marijuana use medication fails period 2b, driving Indivior to review $100M option

.Aelis Farma's hopes of securing a quick, positive selection on a $one hundred million choice settle...

ProKidney standstills phase 3 trial not required for cell therapy authorization

.ProKidney has quit one of a pair of stage 3 trials for its cell treatment for kidney health conditi...

Vaxcyte surges on 'sensational' 31-valent PCV win versus Pfizer

.Vaxcyte introduced what experts called "spectacular" stage 1/2 data for its 31-valent pneumococcal ...

Recursion's mind condition test reveals insufficient documentation of efficacy

.Recursion has discovered through a very early examination of its own tech-enabled strategy to medic...

Acepodia, Pfizer click on all together for chemistry-based cell treatment

.Contact it a case of excellent chemistry: Acepodia, a biotech based on Nobel Prize-winning science,...

Praxis epilepsy medicine reduces seizures in phase 2 hearing

.Practice Preciseness Medicines has racked up one more midphase succeed in epilepsy this year, with ...

Three execs surrender as Dyne blog posts mixed information for DMD applicant

.After escaping a medical grip several years back, Dyne Rehab has actually disclosed brand-new phase...

Arrowhead fires off period 3 information in uncommon metabolic ailment before market clash with Ionis

.Arrowhead Pharmaceuticals has presented its own give in advance of a potential face-off with Ionis,...